259 related articles for article (PubMed ID: 19268184)
41. A comparative study of antipsychotic medication taking in people with schizophrenia.
McCann TV; Deans C; Clark E; Lu S
Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
[TBL] [Abstract][Full Text] [Related]
42. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
Rummel-Kluge C; Schuster T; Peters S; Kissling W
Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of schizophrenia].
Bitter I
Orv Hetil; 2004 Jun; 145(24):1281-3. PubMed ID: 15264758
[No Abstract] [Full Text] [Related]
44. [Schizophrenic patients in the family practice].
Riedel M; Spellmann I; Müller N; Möller HJ
MMW Fortschr Med; 2007 May; 149 Suppl 2():98-101. PubMed ID: 17724979
[TBL] [Abstract][Full Text] [Related]
45. Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy.
Nasrallah HA; Dursun SM
J Psychopharmacol; 2006 Nov; 20(6 Suppl):3-5. PubMed ID: 17046983
[No Abstract] [Full Text] [Related]
46. The long-term treatment of schizophrenia in the community.
Rollin HR
Practitioner; 1982 Jul; 226(1369):1330-3. PubMed ID: 6125936
[No Abstract] [Full Text] [Related]
47. [Treatment of schizophrenia: what the family doctor should know].
Gruber O; Falkai P
MMW Fortschr Med; 2008 May; 150 Suppl 2():16-9; quiz 20. PubMed ID: 18680837
[No Abstract] [Full Text] [Related]
48. Switching antipsychotic medications: a 2-year chart-review study exploring patient characteristics and psychiatric service use of schizophrenia patients.
Schneider AL; Mosier KE; Tempier RP
J Clin Psychiatry; 2009 Jun; 70(6):937-9. PubMed ID: 19573492
[No Abstract] [Full Text] [Related]
49. [Compliance with treatment in schizophrenia and mood disorders].
Sorvaniemi M; Kampman O
Duodecim; 2000; 116(3):277-84. PubMed ID: 11764451
[No Abstract] [Full Text] [Related]
50. Psychopharmacological treatment of schizophrenia.
Lehmann HE
Schizophr Bull; 1975; (13):27-45. PubMed ID: 1851
[No Abstract] [Full Text] [Related]
51. [5 years' experience with prolonged-action neuroleptics].
Lopez-Ibor Aliño JM; Tabares Pujante J
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(5):721-31. PubMed ID: 4150175
[No Abstract] [Full Text] [Related]
52. Medication adherence studies in schizophrenia.
Hamann J; Pitschel-Walz G; Kissling W
Am J Psychiatry; 2004 Mar; 161(3):582; author reply 582-3. PubMed ID: 14992997
[No Abstract] [Full Text] [Related]
53. Dosages and outcomes.
Young AS
Psychiatr Serv; 2003 Nov; 54(11):1547; author reply 1547-8. PubMed ID: 14600319
[No Abstract] [Full Text] [Related]
54. ["Higher outcomes"--optimizing therapy of schizophrenia].
Rüther E
Krankenpfl J; 2004; 42(5-6):151. PubMed ID: 15527215
[No Abstract] [Full Text] [Related]
55. Maintenance therapy in schizophrenia.
Marder SR
Curr Psychiatr Ther; 1983; 22():141-50. PubMed ID: 6145546
[No Abstract] [Full Text] [Related]
56. [Long-term therapy with depot neuroleptics. Prevention of recurrence in chronic schizophrenic patients].
Bergener M; Husser J; Kranzhoff EU; Charap A
Fortschr Med; 1986 Oct; 104(40):756-60. PubMed ID: 2877927
[No Abstract] [Full Text] [Related]
57. Early hospital experience with fluphenazine decanoate.
Small JG; Kellams J
Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
[TBL] [Abstract][Full Text] [Related]
58. How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.
Preskorn SH
J Psychiatr Pract; 2008 May; 14(3):170-5. PubMed ID: 18520787
[No Abstract] [Full Text] [Related]
59. Psychotic recurrence after antipsychotic discontinuation.
Zipursky RB
Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
[No Abstract] [Full Text] [Related]
60. [The long-term treatment of schizophrenia].
Herold R
Orv Hetil; 2012 Jul; 153(26):1007-12. PubMed ID: 22735371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
